Corey S. Cutler, MD, MPH, FRCPC

Articles

Targeted Treatments for GVHD

January 25th 2024

The GVHD experts discuss recent advancements in chronic GVHD treatment, focusing on agents ruxolitinib, ibrutinib, and belumosudil and their mechanisms of action. The panel emphasizes the need for ongoing research and clinical trials to refine treatment strategies.

Expectations of Chronic GVHD Treatment

January 18th 2024

The panel reviews recent developments in treatments, therapeutic approaches post-transplant, and the importance of clear communication in navigating patient expectations.

Monitoring Patients with GVHD

January 18th 2024

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss challenges in detecting and diagnosing chronic GVHD. The panel advocates for vigilant communication, early detection, and ongoing patient education for comprehensive post-transplant care.

Phases of Pathophysiology of Chronic GVHD

January 11th 2024

The expert panel explores the immunological aspects of chronic GVHD, highlighting challenges in simultaneous management, addressing fibrosis, and emphasizing the importance of early intervention in evolving transplant care practices.

Acute Versus Chronic Graft-Versus-Host Disease (GVHD)

January 11th 2024

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.

GvHD: Advice for Patients

February 17th 2023

Experts share their insights and advice on how to best communicate with patients who are actively dealing with acute or chronic GvHD.

Future of Chronic GvHD

February 17th 2023

A look into the future of chronic GvHD and which treatment options patients the panel is most excited about.

Treatment Options: Steroid-Refractory GvHD

February 10th 2023

Experts define and review treatment options for patients with chronic GvHD that are also steroid refractory.

Treatment Options for Chronic GvHD

February 10th 2023

Comprehensive discussion into the available treatment options for patients that present with chronic GvHD.

Defining Chronic Graft vs Host Disease (GvHD)

February 3rd 2023

Panel of oncologists define in chronic GvHD and review the typical presentation of a patient.

Novel Agents in Acute GvHD

February 3rd 2023

Experts discuss new and exciting agents and combinations that are on the horizon for patients with acute GvHD.

Steroid Refractory Acute GvHD and REACH Trials

January 27th 2023

An overview of steroid refractory acute GvHD and a review of the REACH trials that assessed the used of ruxolitinib in patients with GvHD.

Acute GvHD: Clinical Presentation, Risk Factors and Treatment Options

January 27th 2023

Experts discuss the clinical presentation, grading system and review treatment options for patients with acute GvHD.

Future of Acute GvHD Prevention

January 20th 2023

A look into the future of acute GvHD prevention and discussing the impact of targeting specific organs to help manage GvHD prevention.

Clinical Implications of the Phase III BMT CTN 1703 Trial

January 20th 2023

Experts review the Phase III BMT CTN 1703 trial and share how the results of this trial might impact their practice and discuss the role of ATG and abatacept in their practice

Regimens Used for GvHD Prevention

January 13th 2023

A brief review of the different regimens used by experts for GvHD prevention at their institutions and discuss the importance of GvHD Prevention.

An Overview of Graft vs Host Disease (GvHD)

January 13th 2023

Expert oncologists define graft vs host disease (GvHD) and discuss which risk factors might increase a patient’s risk of developing GvHD.

Using Multidisciplinary Care to Optimize Outcomes in GVHD

August 29th 2022

Sharing closing thoughts on acute and chronic GVHD management, expert panelists first consider the value of multidisciplinary care.

Treatment Advances on the Horizon for Acute GVHD

August 22nd 2022

Shifting their focus to acute graft versus host disease, panelists reflect on evolving treatment strategies and novel therapeutics.

Treatment Advances on the Horizon for Chronic GVHD

August 22nd 2022

Expert panelists share their perspectives on ongoing treatment evolutions in the setting of chronic graft versus host disease.